These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 740306)

  • 1. [Tolerance to fosfomycin using greatly elevated doses in the treatment of urinary septicemia in renal insufficiency].
    Neuman M
    Minerva Med; 1978 Dec; 69(59):4105-6. PubMed ID: 740306
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibiotherapy of Serratia marcescens septicemia in children.
    Baquero F; Hortelano JG; Navarro M; Scarpellini A; Jara P; Cañedo T; Rodríguez A
    Chemotherapy; 1977; 23 Suppl 1():416-22. PubMed ID: 318977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of fosfomycin in antibiotic therapy. Its effectiveness in patients with acute renal insufficiency or on hemodialysis treatment].
    Rossi R; Colantonio G; Fraticelli M; Giura C; Quarenghi MI; Polli O; Ferradini MA; Nonini MO
    G Ital Chemioter; 1979; 26(1-2):315-7. PubMed ID: 554823
    [No Abstract]   [Full Text] [Related]  

  • 4. Is experimental endotoxaemia in humans suitable for simulating antibiotic pharmacokinetics in sepsis and septic shock? A pilot study using the model compound fosfomycin.
    Sauermann R; Mayer-Helm BX; Petsch M; Popovic M; Thallinger C; Joukhadar C
    Int J Antimicrob Agents; 2008 Mar; 31(3):291-2. PubMed ID: 18160265
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antibiotic treatment of device-associated endocarditis with fosfomycin and vancomycin in patients with renal insufficiency].
    Bär W; Grosch H; Ahland R; Krülls-Münch J
    Dtsch Med Wochenschr; 2005 Aug; 130(31-32):1818-9. PubMed ID: 16052445
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of fosfomycin in the most frequently recurring pediatric infections].
    Minerva Med; 1978 Dec; 69(59):4129-34. PubMed ID: 740311
    [No Abstract]   [Full Text] [Related]  

  • 7. [Septicemia in chronic hemodialysis patients].
    Ben Hmida M; Hachicha J; Chaabouni MN; Jerraya A
    Tunis Med; 1988 May; 66(5):431-4. PubMed ID: 3206550
    [No Abstract]   [Full Text] [Related]  

  • 8. Fosfomycin: use beyond urinary tract and gastrointestinal infections.
    Falagas ME; Giannopoulou KP; Kokolakis GN; Rafailidis PI
    Clin Infect Dis; 2008 Apr; 46(7):1069-77. PubMed ID: 18444827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical experience with fosfomycin in urinary tract infections (author's transl)].
    Peters HJ; Eicher R
    MMW Munch Med Wochenschr; 1981 May; 123(18):748-50. PubMed ID: 6785627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serratia marcescens septicemia.
    Dodson WH
    Arch Intern Med; 1968 Feb; 121(2):145-50. PubMed ID: 4865738
    [No Abstract]   [Full Text] [Related]  

  • 11. Fosfomycin therapy for multiresistant Pseudomonas aeruginosa in cystic fibrosis.
    Mirakhur A; Gallagher MJ; Ledson MJ; Hart CA; Walshaw MJ
    J Cyst Fibros; 2003 Mar; 2(1):19-24. PubMed ID: 15463841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fosfomycin--a new antibiotic in rhinootolaryngology].
    Stammberger H
    HNO; 1983 Dec; 31(12):436-9. PubMed ID: 6662741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nephrological experiences in the treatment of urinary infections by fosfomycin].
    Mioli V; Figus S
    Minerva Med; 1978 Dec; 69(59):4093-6. PubMed ID: 740305
    [No Abstract]   [Full Text] [Related]  

  • 14. Recurrent septicemia in a renal transplant recipient.
    Nejad-Gashti H; Sanavi S; Afshar R
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):471-3. PubMed ID: 19414955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fosfomycin prescription during production shortage].
    Dinh A; Bru JP; Dresco I; Janus C; Bernard L
    Med Mal Infect; 2008 Jul; 38(7):383-6. PubMed ID: 18550311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro investigations on the action fosfomycin alone and in combination with other antibiotics on Pseudomonas aeruginosa and Serratia marcescens.
    Ullmann U; Lindemann B
    Arzneimittelforschung; 1980; 30(8):1247-9. PubMed ID: 6776966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fosfomycin for Pseudomonas-related exacerbations of cystic fibrosis.
    Faruqi S; McCreanor J; Moon T; Meigh R; Morice AH
    Int J Antimicrob Agents; 2008 Nov; 32(5):461-3. PubMed ID: 18703318
    [No Abstract]   [Full Text] [Related]  

  • 18. [Septicemia and bacteremia due to enterobacteriaceae of the group Klebsiella-Enterobacter-Serratia].
    Taranger C; Tamalet J; Mercier P
    Sem Hop; 1971 Mar; 47(14):866-71. PubMed ID: 4324367
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bacteremia and septicemia due to Serratia marcescens. Apropos of 50 positive hemocultures (26 patients)].
    Vic-Dupont V; Witchitz S; Emile J; Coulaud JP; Amstutz P; Bazin C; Vachon F; Christol D; Duval J
    Ann Med Interne (Paris); 1969; 120(6):395-404. PubMed ID: 4896980
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of metronidazole and fosfomycin alone and in combination in the treatment of experimentally induced intra-abdominal infections.
    Nord CE; Lahnborg G
    Scand J Gastroenterol Suppl; 1984; 90():15-9. PubMed ID: 6588479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.